Neither sequence variation in the IL-10 gene promoter nor presence of IL-10 protein in the cerebral cortex is associated with Alzheimer's disease.
Interleukin 10 (IL-10) is an important anti-inflammatory cytokine produced in response to neuroinflammation and might be involved in modulating the progression of Alzheimer's disease (AD) through inhibiting the action of pro-inflammatory cytokines. We have used immunohistochemistry, Western blo...
Main Authors: | Culpan, D, Prince, J, Matthews, S, Palmer, L, Hughes, A, Love, S, Kehoe, P, Wilcock, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
The expression of the anti-inflammatory cytokine IL-10 in Alzheimer's disease is independent of IL-10 promoter polymorphisms
by: Culpan, D, et al.
Published: (2002) -
Erratum to "TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease" [Culpan et al. (Neurobiol Aging 2009 July;30(7):1052-60)] (DOI:10.1016/j.neurobiolaging.2007.10.014)
by: Culpan, D, et al.
Published: (2010) -
APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease.
by: Chalmers, K, et al.
Published: (2004) -
Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease
by: Combarros, O, et al.
Published: (2009) -
TNFR-associated factor-2 (TRAF-2) expression in Alzheimer's disease
by: Culpan, D, et al.
Published: (2004)